BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8958925)

  • 1. Regulation of IL-12 production by human monocytes and the influence of prostaglandin E2.
    van der Pouw Kraan TC; Boeije LC; Snijders A; Smeenk RJ; Wijdenes J; Aarden LA
    Ann N Y Acad Sci; 1996 Oct; 795():147-57. PubMed ID: 8958925
    [No Abstract]   [Full Text] [Related]  

  • 2. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
    Seldon PM; Barnes PJ; Giembycz MA
    Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production.
    van der Pouw Kraan TC; Boeije LC; Smeenk RJ; Wijdenes J; Aarden LA
    J Exp Med; 1995 Feb; 181(2):775-9. PubMed ID: 7836930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Leishmania protein that modulates interleukin (IL)-12, IL-10 and tumor necrosis factor-alpha production and expression of B7-1 in human monocyte-derived antigen-presenting cells.
    Probst P; Skeiky YA; Steeves M; Gervassi A; Grabstein KH; Reed SG
    Eur J Immunol; 1997 Oct; 27(10):2634-42. PubMed ID: 9368620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2 inhibits Paracoccidioides brasiliensis killing by human monocytes.
    Bordon AP; Dias-Melicio LA; Acorci MJ; Calvi SA; Serrão Peraçoli MT; Victoriano de Campos Soares AM
    Microbes Infect; 2007 May; 9(6):744-7. PubMed ID: 17400014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2 inhibits IL-23 and IL-12 production by human monocytes through down-regulation of their common p40 subunit.
    Kalim KW; Groettrup M
    Mol Immunol; 2013 Mar; 53(3):274-82. PubMed ID: 22982753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The vasoactive intestinal peptide analogue RO25-1553 inhibits the production of TNF and IL-12 by LPS-activated monocytes.
    Dewit D; Gourlet P; Amraoui Z; Vertongen P; Willems F; Robberecht P; Goldman M
    Immunol Lett; 1998 Jan; 60(1):57-60. PubMed ID: 9541464
    [No Abstract]   [Full Text] [Related]  

  • 8. Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor beta1 and beta2 chain expression.
    Braun MC; He J; Wu CY; Kelsall BL
    J Exp Med; 1999 Feb; 189(3):541-52. PubMed ID: 9927516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of forskolin on Kupffer cell production of interleukin-10 and tumor necrosis factor alpha differ from those of endogenous adenylyl cyclase activators: possible role for adenylyl cyclase 9.
    Dahle MK; Myhre AE; Aasen AO; Wang JE
    Infect Immun; 2005 Nov; 73(11):7290-6. PubMed ID: 16239525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of the prostaglandin E2-ethanolamide suppression of tumour necrosis factor-α production in human monocytic cells.
    Brown KL; Davidson J; Rotondo D
    Biochim Biophys Acta; 2013 Jun; 1831(6):1098-107. PubMed ID: 23542062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal cell carcinoma induces interleukin 10 and prostaglandin E2 production by monocytes.
    Ménétrier-Caux C; Bain C; Favrot MC; Duc A; Blay JY
    Br J Cancer; 1999 Jan; 79(1):119-30. PubMed ID: 10408703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutting edge: cyclooxygenase-2 activation suppresses Th1 polarization in response to Helicobacter pylori.
    Meyer F; Ramanujam KS; Gobert AP; James SP; Wilson KT
    J Immunol; 2003 Oct; 171(8):3913-7. PubMed ID: 14530307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA.
    Wagner M; Poeck H; Jahrsdoerfer B; Rothenfusser S; Prell D; Bohle B; Tuma E; Giese T; Ellwart JW; Endres S; Hartmann G
    J Immunol; 2004 Jan; 172(2):954-63. PubMed ID: 14707068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production.
    Rieser C; Böck G; Klocker H; Bartsch G; Thurnher M
    J Exp Med; 1997 Nov; 186(9):1603-8. PubMed ID: 9348319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gram-negative bacteria induce proinflammatory cytokine production by monocytes in the absence of lipopolysaccharide (LPS).
    Uronen H; Williams AJ; Dixon G; Andersen SR; Van Der Ley P; Van Deuren M; Callard RE; Klein N
    Clin Exp Immunol; 2000 Dec; 122(3):312-5. PubMed ID: 11122234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular adenine nucleotides modulate cytokine production by human monocyte-derived dendritic cells: dual effect on IL-12 and stimulation of IL-10.
    Wilkin F; Stordeur P; Goldman M; Boeynaems JM; Robaye B
    Eur J Immunol; 2002 Sep; 32(9):2409-17. PubMed ID: 12207325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-4 suppression of monocyte tumour necrosis factor-alpha production. Dependence on protein synthesis but not on cyclic AMP production.
    Hart PH; Jones CA; Finlay-Jones JJ
    Immunology; 1992 Aug; 76(4):560-5. PubMed ID: 1328039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C5a suppresses the production of IL-12 by IFN-gamma-primed and lipopolysaccharide-challenged human monocytes.
    Wittmann M; Zwirner J; Larsson VA; Kirchhoff K; Begemann G; Kapp A; Götze O; Werfel T
    J Immunol; 1999 Jun; 162(11):6763-9. PubMed ID: 10352296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced prostaglandin E2 production by monocytes in atopic dermatitis (AD) is not accompanied by enhanced production of IL-6, IL-10 or IL-12.
    Snijders A; Van der Pouw Kraan TC; Engel M; Wormmeester J; Widjaja P; Zonneveld IM; Bos JD; Kapsenberg ML
    Clin Exp Immunol; 1998 Mar; 111(3):472-6. PubMed ID: 9528885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell-independent, TLR-induced IL-12p70 production in primary human monocytes.
    Bekeredjian-Ding I; Roth SI; Gilles S; Giese T; Ablasser A; Hornung V; Endres S; Hartmann G
    J Immunol; 2006 Jun; 176(12):7438-46. PubMed ID: 16751389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.